 |
| Aspirin |
Last updated: Nov 05, 2009 |
Aspirin can help with the following: | |  | | | | Circulation | Increased Risk of Stroke | Aspirin reduces platelet 'stickiness' or aggregation as do other natural products that 'thin blood'. The use of aspirin to reduce clotting and stroke risk, even at doses as low as 81mg three times per week, is still controversial. The risks at the lowest doses are low, but the benefit may be limited. Aspirin seems to work better in men with low blood pressure than high, and in men who have had a previous heart attack compared to those who have not. There are many natural substances that can reduce stroke risk with fewer side effects. |
Not recommended for:
Bleeding Tendency | Inflammation |
Chronic Inflammation | Drugs that reduce inflammation are effective, but even the relatively "safe" ones such as aspirin can cause gastritis or even an ulcer. |
| Musculo-Skeletal | Not recommended for:
Gout / Hyperuricemia | Among the more common predisposing factors to hyperuricemia are kidney failure from any cause, diuretic use, dehydration, hormonal diseases, alcohol consumption and using low doses of aspirin. Aspirin, which normally reduces pain, raises uric acid levels and makes gout pain worse! |
| Risks |
Increased Risk of Coronary Disease / Heart Attack | First it was an apple, now it is an aspirin a day that may keep the doctor away. Aspirin has become standard for heart attack prevention, but research published in the online open access journal BMC Medicine suggests that this may really be a man's drug.
Scientists have long puzzled over why the protective effects of aspirin vary so widely between clinical trials. Some trials show no difference between aspirin and placebo, whilst others report that aspirin reduces the risk of a heart attack by more than 50%.
This latest study, from The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research, highlights the influence of gender on aspirin's protective powers. Investigators examined the results of 23 previously published clinical trials for the effect for aspirin in heart attack prevention, involving more than 113,000 patients. The authors then analysed how much the ratio of men to women in these trials affected the trials' outcomes.
"Trials that recruited predominantly men demonstrated the largest risk reduction in non-fatal heart attacks," says Dr Don Sin, one of the study's authors. "The trials that contained predominately women failed to demonstrate a significant risk reduction in these non-fatal events. We found that a lot of the variability in these trials seems to be due to the gender ratios, supporting the theory that women may be less responsive to aspirin than men for heart protection." [] |
|
| |  | |  |
KEY |  | May do some good |  |  | Likely to help |  |  | Avoid absolutely |
|
 |